Fellowship Overview
CytoVas develops cellular assays that can be commercialized as in-vitro diagnostics for the measurement of the personal risk for cardiovascular disease.
Read more
The latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies.
Read more
Pages